Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide and Pioglitazone in Lean Type 2 Diabetes (Lean-DM)
NCT04657939Phase 4Completed
- Sponsor
- University of Leeds
- Start
- Dec 2020
- Primary completion
- Oct 2022
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide, pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by University of Leeds. Started Dec 2020; status: completed.
02
Drugs
liraglutidepioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04657939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04657939.